Patient Guide: Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 50 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06535607
Status: 🟢 Enrolling Now
Condition: Cervical Cancer, Head and Neck Squamous Cell Carcinoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 50 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Los Angeles, California
  • • Baltimore, Maryland
  • • Stony Brook, New York
  • • And 47 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors - Join Clinical Trial NCTNCT06535607

How to Join This Clinical Trial - NCTNCT06535607

Learn how to participate in this PHASE2 trial studying an investigational therapy for Cervical Cancer, Head and Neck Squamous Cell Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Cervical Cancer, Head and Neck Squamous Cell Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Cervical Cancer, Head and Neck Squamous Cell Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06535607 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90025 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Stony Brook, New York 11794 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Ijuí, 98700-000 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Londrina, 86015-520 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

São Caetano do Sul, 09541-270 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Vitória, 29043-260 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Beijing, 100142 - China

Status: RECRUITING

Clinical Research Site

Beijing, 100730 - China

Status: RECRUITING

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Cervical Cancer, Head and Neck Squamous Cell Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation